147 related articles for article (PubMed ID: 38519484)
21. RAS oncogenic activity predicts response to chemotherapy and outcome in lung adenocarcinoma.
East P; Kelly GP; Biswas D; Marani M; Hancock DC; Creasy T; Sachsenmeier K; Swanton C; ; Downward J; de Carné Trécesson S
Nat Commun; 2022 Sep; 13(1):5632. PubMed ID: 36163168
[TBL] [Abstract][Full Text] [Related]
22. Combinatorial immunotherapies overcome MYC-driven immune evasion in triple negative breast cancer.
Lee JV; Housley F; Yau C; Nakagawa R; Winkler J; Anttila JM; Munne PM; Savelius M; Houlahan KE; Van de Mark D; Hemmati G; Hernandez GA; Zhang Y; Samson S; Baas C; Kok M; Esserman LJ; van 't Veer LJ; Rugo HS; Curtis C; Klefström J; Matloubian M; Goga A
Nat Commun; 2022 Jun; 13(1):3671. PubMed ID: 35760778
[TBL] [Abstract][Full Text] [Related]
23. Interleukin-6 mediated inflammasome activation promotes oral squamous cell carcinoma progression via JAK2/STAT3/Sox4/NLRP3 signaling pathway.
Xiao L; Li X; Cao P; Fei W; Zhou H; Tang N; Liu Y
J Exp Clin Cancer Res; 2022 May; 41(1):166. PubMed ID: 35513871
[TBL] [Abstract][Full Text] [Related]
24. Integrative proteogenomic characterization of hepatocellular carcinoma across etiologies and stages.
Ng CKY; Dazert E; Boldanova T; Coto-Llerena M; Nuciforo S; Ercan C; Suslov A; Meier MA; Bock T; Schmidt A; Ketterer S; Wang X; Wieland S; Matter MS; Colombi M; Piscuoglio S; Terracciano LM; Hall MN; Heim MH
Nat Commun; 2022 May; 13(1):2436. PubMed ID: 35508466
[TBL] [Abstract][Full Text] [Related]
25. The Influence of Oncogenic RAS on Chemotherapy and Radiotherapy Resistance Through DNA Repair Pathways.
Cáceres-Gutiérrez RE; Alfaro-Mora Y; Andonegui MA; Díaz-Chávez J; Herrera LA
Front Cell Dev Biol; 2022; 10():751367. PubMed ID: 35359456
[TBL] [Abstract][Full Text] [Related]
26. Compensatory CSF2-driven macrophage activation promotes adaptive resistance to CSF1R inhibition in breast-to-brain metastasis.
Klemm F; Möckl A; Salamero-Boix A; Alekseeva T; Schäffer A; Schulz M; Niesel K; Maas RR; Groth M; Elie BT; Bowman RL; Hegi ME; Daniel RT; Zeiner PS; Zinke J; Harter PN; Plate KH; Joyce JA; Sevenich L
Nat Cancer; 2021 Oct; 2(10):1086-1101. PubMed ID: 35121879
[TBL] [Abstract][Full Text] [Related]
27. Targeting the PI3K/Akt/mTOR Pathway in Hepatocellular Carcinoma.
Sun EJ; Wankell M; Palamuthusingam P; McFarlane C; Hebbard L
Biomedicines; 2021 Nov; 9(11):. PubMed ID: 34829868
[TBL] [Abstract][Full Text] [Related]
28. Ensembl 2022.
Cunningham F; Allen JE; Allen J; Alvarez-Jarreta J; Amode MR; Armean IM; Austine-Orimoloye O; Azov AG; Barnes I; Bennett R; Berry A; Bhai J; Bignell A; Billis K; Boddu S; Brooks L; Charkhchi M; Cummins C; Da Rin Fioretto L; Davidson C; Dodiya K; Donaldson S; El Houdaigui B; El Naboulsi T; Fatima R; Giron CG; Genez T; Martinez JG; Guijarro-Clarke C; Gymer A; Hardy M; Hollis Z; Hourlier T; Hunt T; Juettemann T; Kaikala V; Kay M; Lavidas I; Le T; Lemos D; Marugán JC; Mohanan S; Mushtaq A; Naven M; Ogeh DN; Parker A; Parton A; Perry M; Piližota I; Prosovetskaia I; Sakthivel MP; Salam AIA; Schmitt BM; Schuilenburg H; Sheppard D; Pérez-Silva JG; Stark W; Steed E; Sutinen K; Sukumaran R; Sumathipala D; Suner MM; Szpak M; Thormann A; Tricomi FF; Urbina-Gómez D; Veidenberg A; Walsh TA; Walts B; Willhoft N; Winterbottom A; Wass E; Chakiachvili M; Flint B; Frankish A; Giorgetti S; Haggerty L; Hunt SE; IIsley GR; Loveland JE; Martin FJ; Moore B; Mudge JM; Muffato M; Perry E; Ruffier M; Tate J; Thybert D; Trevanion SJ; Dyer S; Harrison PW; Howe KL; Yates AD; Zerbino DR; Flicek P
Nucleic Acids Res; 2022 Jan; 50(D1):D988-D995. PubMed ID: 34791404
[TBL] [Abstract][Full Text] [Related]
29. Immunotherapies for hepatocellular carcinoma.
Llovet JM; Castet F; Heikenwalder M; Maini MK; Mazzaferro V; Pinato DJ; Pikarsky E; Zhu AX; Finn RS
Nat Rev Clin Oncol; 2022 Mar; 19(3):151-172. PubMed ID: 34764464
[TBL] [Abstract][Full Text] [Related]
30. The Mannose Receptor: From Endocytic Receptor and Biomarker to Regulator of (Meta)Inflammation.
van der Zande HJP; Nitsche D; Schlautmann L; Guigas B; Burgdorf S
Front Immunol; 2021; 12():765034. PubMed ID: 34721436
[TBL] [Abstract][Full Text] [Related]
31. Senescence-Induced Vascular Remodeling Creates Therapeutic Vulnerabilities in Pancreas Cancer.
Ruscetti M; Morris JP; Mezzadra R; Russell J; Leibold J; Romesser PB; Simon J; Kulick A; Ho YJ; Fennell M; Li J; Norgard RJ; Wilkinson JE; Alonso-Curbelo D; Sridharan R; Heller DA; de Stanchina E; Stanger BZ; Sherr CJ; Lowe SW
Cell; 2021 Sep; 184(18):4838-4839. PubMed ID: 34478658
[No Abstract] [Full Text] [Related]
32. Activating a collaborative innate-adaptive immune response to control metastasis.
Sun L; Kees T; Almeida AS; Liu B; He XY; Ng D; Han X; Spector DL; McNeish IA; Gimotty P; Adams S; Egeblad M
Cancer Cell; 2021 Oct; 39(10):1361-1374.e9. PubMed ID: 34478639
[TBL] [Abstract][Full Text] [Related]
33. GM-CSF drives myelopoiesis, recruitment and polarisation of tumour-associated macrophages in cholangiocarcinoma and systemic blockade facilitates antitumour immunity.
Ruffolo LI; Jackson KM; Kuhlers PC; Dale BS; Figueroa Guilliani NM; Ullman NA; Burchard PR; Qin SS; Juviler PG; Keilson JM; Morrison AB; Georger M; Jewell R; Calvi LM; Nywening TM; O'Dell MR; Hezel AF; De Las Casas L; Lesinski GB; Yeh JJ; Hernandez-Alejandro R; Belt BA; Linehan DC
Gut; 2022 Jul; 71(7):1386-1398. PubMed ID: 34413131
[TBL] [Abstract][Full Text] [Related]
34. High S100A9
Liao J; Li JZ; Xu J; Xu Y; Wen WP; Zheng L; Li L
Aging (Albany NY); 2021 Jun; 13(12):16367-16380. PubMed ID: 34157683
[TBL] [Abstract][Full Text] [Related]
35. Multiparametric Analyses of Hepatocellular Carcinoma Somatic Mouse Models and Their Associated Tumor Microenvironment.
Taranto D; Ramirez CFA; Vegna S; de Groot MHP; de Wit N; Van Baalen M; Klarenbeek S; Akkari L
Curr Protoc; 2021 Jun; 1(6):e147. PubMed ID: 34101385
[TBL] [Abstract][Full Text] [Related]
36. Updated treatment recommendations for hepatocellular carcinoma (HCC) from the ESMO Clinical Practice Guidelines.
Vogel A; Martinelli E; ;
Ann Oncol; 2021 Jun; 32(6):801-805. PubMed ID: 33716105
[No Abstract] [Full Text] [Related]
37. NLRP3 inflammasome in cancer and metabolic diseases.
Sharma BR; Kanneganti TD
Nat Immunol; 2021 May; 22(5):550-559. PubMed ID: 33707781
[TBL] [Abstract][Full Text] [Related]
38. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
Sung H; Ferlay J; Siegel RL; Laversanne M; Soerjomataram I; Jemal A; Bray F
CA Cancer J Clin; 2021 May; 71(3):209-249. PubMed ID: 33538338
[TBL] [Abstract][Full Text] [Related]
39. Dendritic Cells Revisited.
Cabeza-Cabrerizo M; Cardoso A; Minutti CM; Pereira da Costa M; Reis e Sousa C
Annu Rev Immunol; 2021 Apr; 39():131-166. PubMed ID: 33481643
[TBL] [Abstract][Full Text] [Related]
40. Hepatocellular carcinoma.
Llovet JM; Kelley RK; Villanueva A; Singal AG; Pikarsky E; Roayaie S; Lencioni R; Koike K; Zucman-Rossi J; Finn RS
Nat Rev Dis Primers; 2021 Jan; 7(1):6. PubMed ID: 33479224
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
